Publication list

  1. Jablonska J, Dittmar KE, Kleinke T, Buer J and Weiss S: Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection with Listeria monocytogenes. Infect Immun. 2007; 75:462-70 IF (2006): 4,0
  2. Forster N, Gallinat S, Jablonska J, Weiss S, Elsässer H-P and Lutz W. ‘p300 protein acetyltransferase-activity suppresses SLElike autoimmune disease in mice’ J Immunol 2007;178:6941-8 IF (2011): 6,06
  3. Becker C, Lienenklaus S, Jablonska J, Bauer H and Weiss S: ‘Retrovirally transduced IFN is posttranscriptionally regulated adding limited therapeutic potency to tumor- specific CD8+ T cells’. J Mol Med. 2007; 85:63-73 IF (2011): 4,82
  4. Ma B, He F, Jablonska J, Winkelbach S, Zeng A-P, Lindenmaier W, Dittmar K.E.: ‘Six- colour segmentation analysis of multi-colour images in the infection studies using Listeria monocytogenes’. Microsc Res Tech 2006; 19; 70: 171-178 IF (2011): 1,68
  5. Ma B, Jablonska J, Lindenmaier W, Dittmar K E ‘Immunohistochemical study of microanatomy of mouse lymph node using vibratome sections’ Acta Histochem 2007; 109:15-28 IF (2011): 1, 17
  6. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S: ‘Containment of tumor colonizing bacteria by host neutrophils’ Canc Res 2008; 68: 2952-60 IF (2011): 7,52
  7. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N, Jablonska J, Edenhofer F, Rajewsky K, Bruder D, Hafner M, Staeheli P. and Weiss S: ’Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo’ J Immunol 2009; 183:3229-36 IF (2011): 5,64
  8. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H and Weiss S: ‘Tumor invasion of Salmonella enterica serovar Typhimurium by vascular disruption’ PLoS One 2009; 4:e6692. IF (2011): 4,35
  9. Jablonska J, Leschner S, Westphal K, Lienenklaus S and Weiss S: ‘Neutrophils responsive to endogenous IFN beta regulate tumor angiogenesis and growth in a mouse tumor model’ J. Clin. Invest. 2010; 120:1151-64 IF (2011): 14,15
  10. Courties G, Seiffart V, Presumey J, Escriou V, Scherman D, Zwerina J, Ruiz G, Zietara N, Jablonska J, Weiss S, Hoffmann A, Jorgensen C, Apparailly F and Gross G: ‘In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells’ Blood 2010; 116: 3505 – 3516. IF (2011): 10,55
  11. Łyszkiewicz M, Ziętara N, Rohde M, Gekara N, Jablonska J, Dittmar K E, and Weiss S: ‘SIGN-R1+MHC II+ cells of the splenic marginal zone – a novel type of resident dendritic cells’ J Leuc Biol 2011; 89:607-15. IF (2011): 4,99
  12. Solodova E, Jablonska J, Weiss S and Linienklaus S: ‘Production of IFN during Listeria monocytogenes Infection is Restricted to Macrophages’. PLOSone 2011; 6:e18543 IF (2011): 4,1
  13. Viegas N, Andzinski L, Wu C.-F, Komoll R, Gekara N, Dittmar K E, Weiss S and Jablonska J: ‘IFN- production by CD27+ NK cells exacerbates Listeria monocytogenes infection in mice by inhibiting granulocyte mobilization’. Eur. J. Immunol. 2013 43(10):2626-37 IF (2013): 4,52
  14. Jablonska J, Andzinski L, Wu C-F, Leschner S and Weiss S: ‘CXCR2-mediated tumor associated neutrophil recruitment is regulated by IFN-β’. Int J Cancer. 2014 Mar 15;134(6):1346-58 IF (2014): 5,09
  15. Jablonska J: „To NET or not to NET” Am. J. Immunol, 2014 DOI 10.3844/ajisp.2014.166.168 IF (2011): 0,967
  16. Andzinski L, Wu C-F, Lienenklaus S, Kracht M, Weiss S and Jablonska J: Delayed apoptosis of tumor associated neutrophils in absence of endogenous IFN-β. Int. J. Cancer. 2015 Feb 1; 136 (3): 572–583 IF (2015): 5,53
  17. Wu C-F, Andzinski L, Zegenhagen L, Lienenklaus S, Weiss S and Jablonska J: “ Type I interferon suppresses neutrophil-mediated pre-metastatic niche formation in the mouse lung”. Int. J. Cancer, 2015 Jan 21; DOI: 10.1002/ijc.29444 IF (2015): 5,5
  18. Andzinski L, Stahnke S, Wu C-F, Gereke M, von Köckritz-Blickwede M, Schilling B, Brandau S and Jablonska J: „Type I IFNs induce N1 anti-tumor polarization of tumor associated neutrophils in mice and human”. Int. J Cancer 2015 Dec 15, DOI: 10.1002/ijc.29945 IF (2015): 5,53
  19. Granot Z and Jablonska J, “Distinct Functions of Neutrophil in Cancer and Its Regulation,” Mediators of Inflammation, 2015 Article doi:10.1155/2015/701067ID 701067. IF (2015): 3,42
  20. Andzinski L, Harati MD, Zyla E, Kasnitz N, Stahnke S, Wu C-F, Gereke M, von Köckritz- Blickwede M, Schilling B, Brandau S, Kanz L, Welte K, Weiss S, Skokowa J, and Jablonska J. ‘The Mechanism of Type I Interferon-Mediated Polarization of Tumor- Associated Neutrophils in Mice and Human’ [published Abstract]. Blood, 2015: 126 (23).IF (2015): 11,84
  21. Nocera D.A., Nuñez N.G., Lienenklaus S, Jablonska J, Weiss S, Roselli E, Araya P, Gatti G, Morón G and Maccioni M: In vivo visualizing the IFN-β response required for tumor growth control in therapeutic model of Poly A:U administration JI 2016 Mar 15;196(6):2860-9. doi: 10.4049/jimmunol.1501044. IF (2015): 4,99
  22. Andzinski L, Spanier J, Arnold B, Kröger A, Kalinke U, Jin L, Weiß S, Lienenklaus S and Jablonska J: „Growing tumors locally induce a STING dependent type I IFN response in myeloid cells”. 2016 Int. J Cancer Apr 26. doi: 10.1002/ijc.30159. IF (2015): 5,53
  23. Pylaeva E, Lang S and Jablonska J: „The essential role of type I interferons in differentiation and activation of tumor associated neutrophils” 2016 Frontiers in Immunology. 7:629. doi: 10.3389/fimmu.2016.00629 IF (2015): 5,67
  24. Jablonska J and Granot Z: ‘Neutrophil, Quo Vadis’ 2017 J. Leuc. Biol. DOI:  10.1189/jlb.3MR0117-015R (IF: 4,17)